2017 CABA Investment & Entrepreneurship Symposium
The annual CABA Investment and Entrepreneurship Symposium is an influential event attracting prominen entrepreneurs, investors, biotech and pharma executives, academic and industry scientists, as well as professionals from the legal, finance, and healthcare fields. The topics of this year’s presentation and discussion will include venture capital investment, partnership & collaboration, entrepreneur experience both in US and China, etc. The symposium provide a great opportunity to network with hundreds of professionals including scientists, entrepreneurs, investors, et al in USA and China. Past symposiums were extremely well attended. We expect this year’s event will see around 200 professionals. The topics include venture capital investment, partnership & collaboration, university technology transfer, entrepreneur experience both in US and China, etc. The symposium provide a great opportunity to network with hundreds of professionals including scientists, entrepreneurs, investors, et al in USA and China.
Admission
CABA members: FREE; Non-members: $30. On-site membership registration available ($30 annual membership fee due, $15 for student).
Parking
Free
Conference Organizing Committee Contact
Yibin Wei, PhD, MBA,
Email: ben.wei@cabaweb.org
WeChat: ucb001
Agenda
08:30am - 9:00am Registration / Continental Breakfast (Foyer)
09:00am - 9:05am Opening Remarks (Auditorium)
Ben Yibin Wei, Ph.D. MBA
Director, BD APAC, PerkinElmer
Chairman, Organizing Committee
09:05am - 9:15am Introduction of Chinese-American BioMedical Association (CABA)
Kevin Fang, Ph.D.
Senior Director, Sunovion
President, Chinese-American BioMedical Association (CABA)
09:15am - 3:30pm Private 1-on-1 Sessions between Investors and Startup Companies (Berkshire Room)
09:15am - 10:35am Session I: Entrepreneurship in Today’s Biotech Industry (Auditorium)
Moderator, Lan Cao, Ph.D. CRISPR Therapeutics
09:15am - 9:35am Rules of the Road – Biotechnology Entrepreneurship
David Lucchino, MBA, Co-founder, President and CEO, Frequency Therapeutics, Incoming Chairman, Board of Directors, Massachusetts Biotechnology Council
09:35am - 9:55am Jacobio, a Novel Accelerator Model for Biotech Start-ups
Yinxiang Wang, Ph.D., Founder and Chairman, Beijing Jacobio Pharmaceuticals
09:55am - 10:15am Building a Biotech Company in China — Personal Experience
Yuelei Shen, Ph.D., Founder & CEO, Beijing Biocytogen Co. Ltd.
10:15am - 10:35am Building a Medical Device Start-up Company in China
Yu Li, MBA., Co-founder, Bowing Medical
10:35am - 10:50am Coffee Break (Foyer)
10:50am - 11:50am Session II: Investors’ Perspective on Biotech Investment and M&A (Auditorium)
Moderator: Youxin Zhang, Ph.D. Navigant
10:50am - 11:10am Crossing Barriers in Cross-border Investment
Yining Zhao, Ph.D., Venture Partner, Lilly Asia Ventures
11:10am - 11:30am Everest Medicines: Building a Partner of Choice in China
Sean Wuxiong Cao, Ph.D., Managing Director, C-Bridge Capital
President and Interim CEO at Everest Medicines
11:30am - 11:50am Recent Acquisition Deals for Cancer Immunotherapy Companies
Han Ying, Ph.D., CSO, Sanpower Group; Global Strategic Consultant, Dendreon
12:00pm - 1:00pm Lunch Break (Dining Room) and Exhibitor Show (Foyer)
1:00pm - 2:20pm Session III: Emerging Technologies in the Biomedical Industry
Introduction of Moderator, Bo Ying, Ph.D. PNA Innovations
Moderator: Jun Wang, Ph.D. VP of Discovery Biology, Shanghai Medicilon Inc.
1:00pm - 1:20pm From Start-up to IPO
Jun Wang, Ph.D., VP of Discovery Biology, Shanghai Medicilon Inc.
1:20pm - 1:20pm How a Protein Company Becomes a Great Partner
Mike Yiding Chen, CEO, Acrobiosystems
1:40pm - 2:00pm Early Investment Opportunities for Biomedical Care in China
Feng Li, Founding Partner, FreeS Fund
2:00pm - 2:20pm From Seed to Exit in 15 Months: the Delinia Story
Lijun Wu, Ph.D., Entrepreneur-In-Residence, Atlas Venture
2:20pm - 3:30pm Session IV: Panel Discussion
All-things-Considered for Biomedical Entrepreneurship and Investment: Technology, Funding, and Legal Issues
Moderator: Jian Shao, MBA, Senior Director, BD & Investment, Simcere of America, Inc.
Jiawen Han, Head of BD, New England, Qilu Pharmaceutical
Chong Xu, Ph.D., Senior Associate, F-Prime Capital
Jing Li, Ph.D., Senior Vice President, Wuxi Biologics
Weimin Tang, Ph.D., Executive Director, Hengrui Therapeutics Inc.
Chen Chen, Ph.D. J.D., Cooley LLP
Geoffrey Spolyar, J.D., Cooley LLP
3:30pm - 3:50pm Coffee Break (Foyer)
3:50pm - 4:50pm Startup Pitch Competition
4:50pm - 5:30pm CABA High School Student Research Award & Startup Pitch Award
Susan Qu, Ph.D. MBA, Sanofi Genzyme
Cindy Yang, MBA, Biogen
5:30pm - 5:35pm Closing Remark (Auditorium)
6:00pm - 7:30pm Cocktail Reception (Berkshire room. Ticket sold separately)
